Spectrum Management Group’s Gilead Sciences GILD Stock Holding History

Spectrum Management Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-165	Closed	-$12K	–	332
2021 Q4	$12K	Hold	165	–	–	﹤0.01%	214
2021 Q3	$12K	Buy	+165	New	+$11.6K	﹤0.01%	265
2019 Q2	–	Sell	-251	Closed	-$16K	–	248
2019 Q1	$16K	Buy	+251	New	+$16.7K	﹤0.01%	189
2018 Q1	–	Sell	-200	Closed	-$14K	–	246
2017 Q4	$14K	Sell	200 -21	-10%	-$1.59K	﹤0.01%	186
2017 Q3	$18K	Buy	+221	New	+$16.9K	0.01%	242
2016 Q2	–	Sell	-200	Closed	-$18K	–	137
2016 Q1	$18K	Sell	200 -820	-80%	-$73.9K	0.01%	173
2015 Q4	$103K	Buy	1,020 +920	+920%	+$95.7K	0.04%	84
2015 Q3	$10K	Hold	100	–	–	0.01%	143
2015 Q2	$12K	Hold	100	–	–	﹤0.01%	91
2015 Q1	$10K	Hold	100	–	–	﹤0.01%	90
2014 Q4	$9K	Hold	100	–	–	﹤0.01%	105
2014 Q3	$11K	Hold	100	–	–	0.01%	96
2014 Q2	$8K	Hold	100	–	–	0.01%	109
2014 Q1	$7K	Hold	100	–	–	﹤0.01%	113
2013 Q4	$8K	Buy	+100	New	+$6.96K	0.01%	125

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Spectrum Management Group's GILD Position: Q1 2022 in Review

Spectrum Management Group sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 165 shares — an estimated $12K sold.

Spectrum Management Group first reported a position in GILD in Q4 2013 and held it in 15 quarters. The position peaked at $103K in Q4 2015. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

Spectrum Management Group reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
Spectrum Management Group sold 165 Gilead Sciences shares in Q1 2022, an estimated $12K.
Spectrum Management Group first reported a position in Gilead Sciences in Q4 2013 and held it in 15 quarters.
Spectrum Management Group's Gilead Sciences position peaked at $103K in Q4 2015.
1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Spectrum Management Group's 13F filing for Q1 2022, filed 5 May 2022.